7.10.2021 – MindMaze Group secures USD 125 million financing to accelerate commercialization and expansion of its digital neurotherapeutics platform.
MindMaze, an EPFL startup and a global pioneer in the multibillion-dollar digital neurotherapeutics market, today announced the closing of a USD 125 million investment round that will be utilized to drive the continued growth of its SaaS-based digital neurotherapeutics platform.
The financing was provided by AlbaCore Capital Group, one of Europe’sleading specialist investors focusing on public and private corporate credit markets. MindMaze will use the proceeds to accelerate commercialization of, and enhance market access for, its approved and reimbursed neuro-rehabilitation platform, particularly in North America and Europe, and expand its neuro-restorative portfolio through further system development and clinical trials in additional indications including acute stroke, Parkinson disease, Alzheimer disease, traumatic brain injury, multiple sclerosis and aging.
The investment in MindMaze represents one of the top-three private capital raises in the Continental European digital health space and will serve to bolster one of the premier European HealthTech leaders.
Source: Press release MindMaze